查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830871

就地檢驗（POC​​T）全球市場報告（2025年）

Point-Of-Care-Testing (POCT) Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，就地檢驗（POC​​T）市場規模快速擴張，從2024年的454.5億美元成長到2025年的507.9億美元，複合年成長率達11.8%。這段時期的成長可歸因於對個人化醫療的日益重視、醫療基礎設施投資的增加、急診病例數量的增加、照護現場分子檢測的日益普及以及人工智慧在診斷領域日益廣泛的應用。

預計未來幾年，就地檢驗（POC​​T）市場將快速成長，到2029年市場規模將達到781.9億美元，複合年成長率（CAGR）為11.4%。預測期內的成長可歸因於個人化醫療需求的不斷成長、遠端醫療和遠距監測的日益普及、新興市場醫療保健服務可及性的提高、在非傳統醫療環境中的廣泛應用以及穿戴式診斷設備的日益普及。預測期內的主要趨勢包括多重檢測平台的演進、可攜式分子診斷設備的開發、基於智慧型手機的診斷工具的創新、連接性和數據整合能力的提升以及人工智慧驅動的POCT解決方案的出現。

就地檢驗（POC​​T）是指在患者接受治療的地點或附近進行的診斷檢測，可提供即時結果，從而加速臨床決策。其目標是在患者接受治療的地點直接提供快速且準確的診斷訊息，以促進及時治療並改善患者預後。

就地檢驗(POCT) 的主要類型包括血糖值檢測、傳染病檢查、心臟標記檢測、血液凝固檢驗、懷孕和不孕症檢測、血液氣體和電解質檢測以及尿液檢查。血糖值檢測測量血液中的糖（葡萄糖）含量，用於監測和管理相關疾病。 POCT 產品有多種購買管道，包括非處方藥和處方箋藥，並採用免疫檢測、分子診斷、微生物檢測、聚合酵素鏈鎖反應(PCR) 檢測和生物化學檢驗等技術。主要終端使用者包括臨床實驗室、門診醫療機構、醫生診所、藥局、零售診所、電商平台、醫院、加護治療中心、急診中心、居家醫療、自我檢測。

美國關稅的快速上漲以及由此引發的貿易摩擦將持續到2025年，這對醫療設備行業產生了重大影響，尤其是進口診斷成像設備部件、手術用不銹鋼和塑膠耗材。醫院和診所都在抵制價格上漲，這擠壓了製造商的淨利率。監管障礙也加劇了這個問題，因為與關稅相關的供應商變更通常需要重新認證設備，從而延緩了產品上市時間。企業正透過關鍵零件的雙重採購、擴大國內同質化產品的生產以及加速研發經濟高效材料來降低風險。

本研究報告是就地檢驗 ）最新系列報告的一部分，提供全球就地檢驗（POC​​T）行業的市場統計數據，包括市場規模、區域佔有率、競爭對手及其市場佔有率、詳細的市場細分、市場趨勢和商業機會，為您提供在即時檢測（POC​​T）行業取得成功所需的全部數據。本市場研究報告對行業現狀和未來發展趨勢進行了詳細分析，為您提供全面的市場概覽。

遠端醫療的日益普及預計將推動就地檢驗（POC​​T）市場的成長。遠端醫療透過視訊通話、電話和安全即時通訊方式提供遠距醫療服務，由於人們對便利、及時和非接觸式醫療服務的需求不斷成長，遠距醫療正日益普及，而新冠疫情加速了這一趨勢。 POCT與遠端醫療相輔相成，能夠快速且可靠地將診斷結果即時共用給遠距醫療服務提供者。例如，根據Rock Health在2023年2月對8014名受訪者進行的調查，55歲及以上人群中有76%使用過遠端醫療，所有受訪者中有80%至少使用過一次遠端醫療，比2021年成長了8%。

POCT（即時檢測）市場的企業正在利用智慧設備解決方案來簡化工作流程、輔助決策並改善患者預後。例如，血糖管理解決方案能夠即時監測和控制糖尿病患者的血糖值。 2022年1月，瑞士製藥公司羅氏（F. Hoffmann-La Roche AG）推出了Cobas Pulse系統，這是一個將先進的POCT血糖監測與智慧型設備整合結合的互聯平台。該系統能夠自動將檢測結果傳輸到醫院的IT系統，並透過醫療保健應用程式支援臨床決策，從而簡化患者在家門口的診斷流程。

2024年8月，美國醫療檢測公司Quest Diagnostics Inc.以10億美元（約13.5億加幣）收購了LifeLabs LP。此次收購使Quest Diagnostics Inc.能夠擴展其即時檢測服務，並提升創新診斷解決方案的可近性。 LifeLabs LP是一家總部位於加拿大的即時檢測服務提供者。

就地檢驗(POCT) 市場包括提供現場診斷檢測、快速疾病檢測、行動醫療篩檢和患者自測支援等服務的營業單位所獲得的收益。市場價值還包括服務提供者銷售的或包含在其服務產品中的相關產品的價值。就地檢驗(POCT) 市場包括手持式糖化血紅素 (HbA1c) 分析儀、手持式血液氣體分析儀、C反應蛋白 (CRP)檢測套組、多重呼吸道病原體檢測套件和側向流動尿液分析儀的銷售。該市場的價值為“出廠價”，即產品製造商或創建者向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場的產品價值還包括產品創建者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球就地檢驗（POC​​T）：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球就地檢驗（POC​​T）市場：成長率分析
  • 全球就地檢驗（POC​​T）市場表現：規模與成長，2019-2024年
  • 全球就地檢驗（POC​​T）市場預測：規模與成長，2024-2029年，2034年
  • 全球就地檢驗（POC​​T）：潛在市場規模（TAM）

第6章 市場細分

  • 全球就地檢驗（POC​​T）市場按類型、性能和預測分類，2019-2024年、2024-2029年、2034年
  • 血糖值檢測
  • 傳染病檢查
  • 心臟標記檢測
  • 血液凝固檢驗
  • 妊娠和不孕症檢查
  • 血氣和電解質檢查
  • 尿液檢查
  • 其他
  • 全球就地檢驗（POC​​T）市場按購買類型、性能和預測分類，2019-2024年、2024-2029年、2034年
  • 非處方藥
  • 處方箋
  • 全球就地檢驗（POC​​T）市場：按技術、性能和預測分類，2019-2024年、2024-2029年、2034年
  • 免疫檢測
  • 分子診斷
  • 微生物檢測
  • 聚合酵素鏈鎖反應（PCR）檢測
  • 生物化學檢驗
  • 全球就地檢驗（POC​​T）市場按最終用戶、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 臨床實驗室
  • 門診醫療機構及診所
  • 藥局
  • 零售診所/電子商務平台
  • 醫院
  • 加護治療中心
  • 急診中心
  • 居家醫療/自我檢測
  • 其他
  • 全球就地檢驗（POC​​T）市場：血糖值檢測細分市場，按類型、性能和預測，2019-2024年、2024-2029年、2034年
  • 自測血糖儀
  • 連續血糖監測設備
  • 瞬感血糖監測裝置
  • 全球就地檢驗（POC​​T）市場：傳染病檢查細分市場，按類型、性能和預測，2019-2024年、2024-2029年、2034年
  • 人類免疫力缺乏病毒（HIV）檢測
  • 肝炎檢測
  • 流感檢測
  • 新冠病毒檢測
  • 其他傳染病檢查
  • 全球就地檢驗（POC​​T）市場：心臟標記檢測細分市場，按類型、性能和預測，2019-2024年、2024-2029年、2034年
  • 肌鈣蛋白檢測
  • 肌酸激酶MB（CK-MB）檢測
  • 肌紅蛋白檢測
  • B型鈉尿肽（BNP）檢測
  • 全球就地檢驗（POC​​T）市場：血液凝固檢驗細分市場，按類型、性能和預測（2019-2024年、2024-2029年、2034年）
  • 凝血酶原時間（PT）檢測
  • 活化部份凝血活酵素時間（aPTT）檢測
  • 國際標準化比值（INR）檢測
  • 全球就地檢驗（POC​​T）市場：妊娠和不孕症檢測細分市場，按類型、性能和預測，2019-2024年、2024-2029年、2034年
  • 檢測套組
  • 排卵檢測套組
  • 生殖荷爾蒙檢測
  • 全球就地檢驗（POC​​T）市場：血氣和電解質檢測細分市場，按類型、性能和預測，2019-2024年、2024-2029年、2034年
  • 動脈血氣檢測
  • 靜脈血氣檢測
  • 電解質測試（鈉、鉀、氯）
  • 全球就地檢驗（POC​​T）市場：尿液檢查細分市場，按類型、性能和預測，2019-2024年、2024-2029年、2034年
  • 尿液化學分析
  • 尿液顯微鏡分析
  • 尿液培養
  • 全球就地檢驗（POC​​T）市場：其他細分市場、按類型、性能和預測分類，2019-2024年、2024-2029年、2034年
  • 藥物濫用檢測
  • 過敏測試
  • 膽固醇檢測
  • 甲狀腺功能檢查

第7章 區域和國家分析

  • 全球就地檢驗（POC​​T）市場：區域表現及預測，2019-2024年、2024-2029年及2034年
  • 全球就地檢驗（POC​​T）市場：國家/地區、績效及預測，2019-2024年、2024-2029年、2034年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 就地檢驗（POC​​T）市場：競爭格局
  • 就地檢驗（POC​​T）市場：公司概況
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Siemens Healthineers AG
  • Becton Dickinson and Company
  • Zoetis Inc.
  • BioMerieux SA
  • QuidelOrtho Corporation
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Nova Biomedical Corporation
  • LifeScan Inc.
  • Ascensia Diabetes Care Holdings AG
  • Trividia Health Inc.
  • Trinity Biotech Plc
  • SiPhox Inc.
  • Sinocare Inc.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 就地檢驗2029：提供新機會的國家
  • 就地檢驗（POC​​T）市場2029：充滿新機會的細分市場
  • 就地檢驗(POCT) 市場 2029 年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r37862

Point-of-care testing (POCT) refers to diagnostic testing conducted at or near the site of patient care, providing immediate results and enabling faster clinical decision-making. Its purpose is to deliver quick and accurate diagnostic information directly at the point of care, facilitating timely treatment and improved patient outcomes.

The primary types of point-of-care testing (POCT) include blood glucose testing, infectious disease testing, cardiac marker testing, coagulation testing, pregnancy and fertility testing, blood gas or electrolyte testing, urinalysis testing, and others. Blood glucose testing involves measuring the amount of sugar (glucose) in a person's blood to monitor and manage related conditions. POCT products are available through various purchase modes, including over-the-counter and prescription-based products, and utilize technologies such as immunoassays, molecular diagnostics, microbial detection, polymerase chain reaction (PCR) testing, and biochemical testing. Key end users include clinical laboratories, ambulatory care facilities, physician offices, pharmacies, retail clinics, e-commerce platforms, hospitals, critical care centers, urgent care centers, home care and self-testing, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The point-of-care-testing (POCT) market research report is one of a series of new reports from The Business Research Company that provides point-of-care-testing (POCT) market statistics, including the point-of-care-testing (POCT) industry global market size, regional shares, competitors with the point-of-care-testing (POCT) market share, detailed point-of-care-testing (POCT) market segments, market trends, and opportunities, and any further data you may need to thrive in the point-of-care-testing (POCT) industry. This point-of-care-testing (POCT) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The point-of-care-testing (POCT) market size has grown rapidly in recent years. It will grow from $45.45 billion in 2024 to $50.79 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth during the historical period can be attributed to a growing focus on personalized medicine, increasing investments in healthcare infrastructure, a rise in emergency care cases, expanded use of point-of-care molecular testing, and greater integration of AI in diagnostics.

The point-of-care-testing (POCT) market size is expected to see rapid growth in the next few years. It will grow to $78.19 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth during the forecast period can be attributed to increasing demand for personalized medicine, expanding telehealth and remote monitoring trends, rising healthcare access in emerging markets, broader application in non-traditional settings, and growing adoption of wearable diagnostic devices. Key trends expected in the forecast period include advancements in multiplex testing platforms, development of portable molecular diagnostic devices, innovations in smartphone-based diagnostic tools, improvements in connectivity and data integration, and the emergence of AI-powered POCT solutions.

The increasing adoption of telemedicine is expected to drive growth in the point-of-care testing (POCT) market. Telemedicine delivering healthcare remotely via video calls, phone, or secure messaging has gained traction due to rising demand for convenient, timely, and contact-free care, a trend accelerated by the COVID-19 pandemic. POCT complements telemedicine by enabling rapid, reliable diagnostic results that can be shared instantly with remote healthcare providers. For example, a February 2023 survey by Rock Health of 8,014 respondents found that 76% of individuals over 55 had used telemedicine, and 80% of all participants had accessed care remotely at least once, up 8% from 2021.

Companies in the POCT market are leveraging smart device-enabled solutions to improve workflow efficiency, decision support, and patient outcomes in near-patient settings. Blood glucose management solutions, for instance, allow for real-time monitoring and control of blood sugar levels in patients with diabetes. In January 2022, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, launched the Cobas Pulse system, a connected platform combining advanced POCT blood glucose testing with smart device integration. The system enables automatic result transfer to hospital IT systems and supports clinical decision-making through healthcare apps, streamlining near-patient diagnostics.

In August 2024, Quest Diagnostics Inc., a US-based medical laboratory company, acquired LifeLabs LP for $1 billion (CAN $1.35 billion). This acquisition expands Quest Diagnostics' POCT offerings and strengthens access to innovative diagnostic solutions. LifeLabs LP is a Canada-based provider of point-of-care testing services.

Major players in the point-of-care-testing (POCT) market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Zoetis Inc., BioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, SiPhox Inc., and Sinocare Inc.

North America was the largest region in the point-of-care testing (POCT) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in point-of-care testing (POCT) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the point-of-care testing (POCT) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point-of-care testing (POCT) market includes revenues earned by entities by providing services such as on-site diagnostic testing, rapid disease detection, mobile health screening, and patient self-testing support. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care testing (POCT) market includes sales of portable HbA1c analyzers, handheld blood gas analyzers, CRP (C-reactive protein) test kits, multiplex respiratory pathogen detection kits, and lateral flow urine analysis devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point-Of-Care-Testing (POCT) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point-of-care-testing (poct) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point-of-care-testing (poct) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point-of-care-testing (poct) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Blood Glucose Testing; Infectious Diseases Testing; Cardiac Markers Testing; Coagulation Testing; Pregnancy And Fertility Testing; Blood Gas Or Electrolytes Testing; Urinalysis Testing; Other Types
  • 2) By Mode Of Purchase: Over-The-Counter Products; Prescribed Based Products
  • 3) By Technology: Immunoassays; Molecular Diagnostics; Microbial Detection; Polymerase Chain Reaction (PCR) Testing; Biochemical Testing
  • 4) By End-User: Clinical Laboratories; Ambulatory Care Facilities And Physician Offices; Pharmacies; Retail Clinics And E-Comm Platforms; Hospitals; Critical Care Centres; Urgent Care Centres; Home Care And Self-Testing; Other End-Users
  • Subsegments:
  • 1) By Blood Glucose Testing: Self-Monitoring Blood Glucose Devices; Continuous Glucose Monitoring Devices; Flash Glucose Monitoring Devices
  • 2) By Infectious Diseases Testing: Human Immunodeficiency Virus (HIV) Testing; Hepatitis Testing; Influenza Testing; COVID-19 Testing; Other Infectious Diseases Testing
  • 3) By Cardiac Markers Testing: Troponin Testing; Creatine Kinase-MB (CK-MB) Testing; Myoglobin Testing; B-type Natriuretic Peptide (BNP) Testing
  • 4) By Coagulation Testing: Prothrombin Time (PT) Testing; Activated Partial Thromboplastin Time (aPTT) Testing; International Normalized Ratio (INR) Testing
  • 5) By Pregnancy And Fertility Testing: Pregnancy Test Kits; Ovulation Test Kits; Fertility Hormone Testing
  • 6) By Blood Gas Or Electrolytes Testing: Arterial Blood Gas Testing; Venous Blood Gas Testing; Electrolyte Testing
  • 7) By Urinalysis Testing: Urine Chemistry Analysis; Microscopic Urine Analysis; Urine Culture Testing
  • 8) By Other Types: Drug Abuse Testing; Allergy Testing; Cholesterol Testing; Thyroid Function Testing
  • Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Becton Dickinson and Company; Zoetis Inc.; BioMerieux SA; QuidelOrtho Corporation; Sysmex Corporation; Bio-Rad Laboratories Inc.; QIAGEN NV; Nova Biomedical Corporation; LifeScan Inc.; Ascensia Diabetes Care Holdings AG; Trividia Health Inc.; Trinity Biotech Plc; SiPhox Inc.; Sinocare Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Point-Of-Care-Testing (POCT) Market Characteristics

3. Point-Of-Care-Testing (POCT) Market Trends And Strategies

4. Point-Of-Care-Testing (POCT) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Point-Of-Care-Testing (POCT) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Point-Of-Care-Testing (POCT) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Point-Of-Care-Testing (POCT) Market Growth Rate Analysis
  • 5.4. Global Point-Of-Care-Testing (POCT) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Point-Of-Care-Testing (POCT) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Point-Of-Care-Testing (POCT) Total Addressable Market (TAM)

6. Point-Of-Care-Testing (POCT) Market Segmentation

  • 6.1. Global Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Glucose Testing
  • Infectious Diseases Testing
  • Cardiac Markers Testing
  • Coagulation Testing
  • Pregnancy And Fertility Testing
  • Blood Gas Or Electrolytes Testing
  • Urinalysis Testing
  • Other Types
  • 6.2. Global Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Over-The-Counter Products
  • Prescribed Based Products
  • 6.3. Global Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunoassays
  • Molecular Diagnostics
  • Microbial Detection
  • Polymerase Chain Reaction (PCR) Testing
  • Biochemical Testing
  • 6.4. Global Point-Of-Care-Testing (POCT) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Laboratories
  • Ambulatory Care Facilities And Physician Offices
  • Pharmacies
  • Retail Clinics And E-Comm Platforms
  • Hospitals
  • Critical Care Centres
  • Urgent Care Centres
  • Home Care And Self-Testing
  • Other End-Users
  • 6.5. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Blood Glucose Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Self-Monitoring Blood Glucose Devices
  • Continuous Glucose Monitoring Devices
  • Flash Glucose Monitoring Devices
  • 6.6. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Infectious Diseases Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Human Immunodeficiency Virus (HIV) Testing
  • Hepatitis Testing
  • Influenza Testing
  • COVID-19 Testing
  • Other Infectious Diseases Testing
  • 6.7. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Cardiac Markers Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Troponin Testing
  • Creatine Kinase-MB (CK-MB) Testing
  • Myoglobin Testing
  • B-type Natriuretic Peptide (BNP) Testing
  • 6.8. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Coagulation Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prothrombin Time (PT) Testing
  • Activated Partial Thromboplastin Time (aPTT) Testing
  • International Normalized Ratio (INR) Testing
  • 6.9. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Pregnancy And Fertility Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pregnancy Test Kits
  • Ovulation Test Kits
  • Fertility Hormone Testing
  • 6.10. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Blood Gas Or Electrolytes Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Arterial Blood Gas Testing
  • Venous Blood Gas Testing
  • Electrolyte Testing (Sodium, Potassium, Chloride)
  • 6.11. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Urinalysis Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urine Chemistry Analysis
  • Microscopic Urine Analysis
  • Urine Culture Testing
  • 6.12. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Abuse Testing
  • Allergy Testing
  • Cholesterol Testing
  • Thyroid Function Testing

7. Point-Of-Care-Testing (POCT) Market Regional And Country Analysis

  • 7.1. Global Point-Of-Care-Testing (POCT) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Point-Of-Care-Testing (POCT) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Point-Of-Care-Testing (POCT) Market

  • 8.1. Asia-Pacific Point-Of-Care-Testing (POCT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Point-Of-Care-Testing (POCT) Market

  • 9.1. China Point-Of-Care-Testing (POCT) Market Overview
  • 9.2. China Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Point-Of-Care-Testing (POCT) Market

  • 10.1. India Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Point-Of-Care-Testing (POCT) Market

  • 11.1. Japan Point-Of-Care-Testing (POCT) Market Overview
  • 11.2. Japan Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Point-Of-Care-Testing (POCT) Market

  • 12.1. Australia Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Point-Of-Care-Testing (POCT) Market

  • 13.1. Indonesia Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Point-Of-Care-Testing (POCT) Market

  • 14.1. South Korea Point-Of-Care-Testing (POCT) Market Overview
  • 14.2. South Korea Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Point-Of-Care-Testing (POCT) Market

  • 15.1. Western Europe Point-Of-Care-Testing (POCT) Market Overview
  • 15.2. Western Europe Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Point-Of-Care-Testing (POCT) Market

  • 16.1. UK Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Point-Of-Care-Testing (POCT) Market

  • 17.1. Germany Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Point-Of-Care-Testing (POCT) Market

  • 18.1. France Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Point-Of-Care-Testing (POCT) Market

  • 19.1. Italy Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Point-Of-Care-Testing (POCT) Market

  • 20.1. Spain Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Point-Of-Care-Testing (POCT) Market

  • 21.1. Eastern Europe Point-Of-Care-Testing (POCT) Market Overview
  • 21.2. Eastern Europe Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Point-Of-Care-Testing (POCT) Market

  • 22.1. Russia Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Point-Of-Care-Testing (POCT) Market

  • 23.1. North America Point-Of-Care-Testing (POCT) Market Overview
  • 23.2. North America Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Point-Of-Care-Testing (POCT) Market

  • 24.1. USA Point-Of-Care-Testing (POCT) Market Overview
  • 24.2. USA Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Point-Of-Care-Testing (POCT) Market

  • 25.1. Canada Point-Of-Care-Testing (POCT) Market Overview
  • 25.2. Canada Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Point-Of-Care-Testing (POCT) Market

  • 26.1. South America Point-Of-Care-Testing (POCT) Market Overview
  • 26.2. South America Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Point-Of-Care-Testing (POCT) Market

  • 27.1. Brazil Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Point-Of-Care-Testing (POCT) Market

  • 28.1. Middle East Point-Of-Care-Testing (POCT) Market Overview
  • 28.2. Middle East Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Point-Of-Care-Testing (POCT) Market

  • 29.1. Africa Point-Of-Care-Testing (POCT) Market Overview
  • 29.2. Africa Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Point-Of-Care-Testing (POCT) Market Competitive Landscape And Company Profiles

  • 30.1. Point-Of-Care-Testing (POCT) Market Competitive Landscape
  • 30.2. Point-Of-Care-Testing (POCT) Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Point-Of-Care-Testing (POCT) Market Other Major And Innovative Companies

  • 31.1. Siemens Healthineers AG
  • 31.2. Becton Dickinson and Company
  • 31.3. Zoetis Inc.
  • 31.4. BioMerieux SA
  • 31.5. QuidelOrtho Corporation
  • 31.6. Sysmex Corporation
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. QIAGEN NV
  • 31.9. Nova Biomedical Corporation
  • 31.10. LifeScan Inc.
  • 31.11. Ascensia Diabetes Care Holdings AG
  • 31.12. Trividia Health Inc.
  • 31.13. Trinity Biotech Plc
  • 31.14. SiPhox Inc.
  • 31.15. Sinocare Inc.

32. Global Point-Of-Care-Testing (POCT) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Point-Of-Care-Testing (POCT) Market

34. Recent Developments In The Point-Of-Care-Testing (POCT) Market

35. Point-Of-Care-Testing (POCT) Market High Potential Countries, Segments and Strategies

  • 35.1 Point-Of-Care-Testing (POCT) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Point-Of-Care-Testing (POCT) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Point-Of-Care-Testing (POCT) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer